Akso Health Group (AHG) director Xie Zhongliang files initial Form 3

Rhea-AI Filing Summary

Akso Health Group director Xie Zhongliang has filed an initial Form 3, which is the first statement of beneficial ownership for a company insider. This filing establishes his status as a director and, in this excerpt, does not report any insider transactions or derivative positions.

Key Terms

Form 3, beneficial ownership, reporting insider

3 terms

Form 3 regulatory

"has filed an initial Form 3, which is the first statement"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"which is the first statement of beneficial ownership for a company insider"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting insider regulatory

"identifies when someone becomes a reporting insider at Akso Health Group"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Xie Zhongliang

(Last) (First) (Middle)

2ND FLOOR, QIANTONGYUAN BUILDING,

NO.44,MOSCOW ROAD,

(Street)

QINGDAO 266000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/06/2026

3. Issuer Name and Ticker or Trading Symbol
Akso Health Group [ AHG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Zhongliang Xie	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Akso Health Group (AHG) Form 3 filing for Xie Zhongliang show?

The Form 3 filing shows that Xie Zhongliang is a director of Akso Health Group. It serves as his initial statement of beneficial ownership and, in this excerpt, reports no insider transactions or derivative holdings.

Is Akso Health Group director Xie Zhongliang buying or selling AHG shares in this Form 3?

This Form 3 for Xie Zhongliang does not report any share purchases or sales. The transaction summary shows zero buys, sells, exercises, gifts, tax withholdings, or restructurings in the provided data.

Why is a Form 3 important for Akso Health Group (AHG) investors?

A Form 3 identifies when someone becomes a reporting insider at Akso Health Group. It establishes baseline disclosure of that person’s beneficial ownership and is a starting point for tracking future Form 4 and Form 5 insider activity.

Does the Akso Health Group Form 3 include any derivative securities for Xie Zhongliang?

The provided Form 3 data shows an empty derivativeSummary for Xie Zhongliang. That means there are no derivative transactions or positions, such as options or warrants, disclosed in this particular excerpt.

What transaction activity is summarized for AHG director Xie Zhongliang in this Form 3?

The transactionSummary lists zero counts for buys, sells, exercises, gifts, tax withholdings, restructurings, and derivative transactions. It also shows netBuySellDirection as neutral, indicating no reported trading activity in this filing.